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PITX3 expression is confined to adult midbrain dopaminergic (mDA) neurons. In
this study we describe the generation and basic functional characteristics of mDA
neurons derived from a human pluripotent stem cell (hPSC) line expressing eGFP
under the control of the PITX3 promoter. Flow cytometry showed that eGFP was
evident in 15% of the neuron population at day 12 of differentiation and this level
was maintained until at least day 80. From days 20 to 80 of differentiation intracellular
chloride decreased and throughout this period around ∼20% of PITX3eGFP/w neurons
exhibited spontaneous Ca2+ transients (from 3.3 ± 0.3 to 5.0 ± 0.1 min−1,
respectively). These neurons also responded to any of ATP, glutamate, acetylcholine,
or noradrenaline with elevations of intracellular calcium. As neuronal cultures matured
more dopamine was released and single PITX3eGFP/w neurons began to respond
to more than one neurotransmitter. MPP+ and tumor necrosis factor (TNF), but not
prostaglandin E eGFP/w2, caused death of the ∼50% of PITX3 neurons (day 80). Tracking
eGFP using time lapse confocal microscopy over 24 h demonstrated significant TNF-
mediated neurite retraction over time. This work now shows that these PITX3eGFP/w
neurons are amenable to flow cytometry, release dopamine and respond to multiple
neurotransmitters with elevations of intracellular calcium, we believe that they represent
a versatile system for neuropharmacological and neurotoxicological studies.
Keywords: in vitro neurodegenerative modeling, human embryonic stem cells, functional characterization,
midbrain dopaminergic neurons
Introduction
Since Parkinson’s disease (PD) has no cure current therapeutics target motor systems to either
increase dopamine production or adjust the impact of other neurotransmitters, but these treat-
ments are likely to eventually fail. Human pluripotent stem cell (hPSC) derived midbrain
dopaminergic (mDA) neurons have captured the imagination of public and scientists alike as
a source of cells for disease arresting cell replacement therapies for PD (Kim et al., 2002;
Lindvall et al., 2004). However, our contention is that hPSC-derived mDA neurons, with
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genetic modiﬁcations designed to enhance their utility, could
promote the next generation of in vitro pathophysiological mod-
eling and drug discovery studies. Recent modeling studies have
used reprogramming technology to generate hPSCs derivedmDA
neurons from patients with PD with an aim to speciﬁcally inves-
tigate the role of single gene mutations on neuron function
and survival (Devine et al., 2011; Nguyen et al., 2011; Sanchez-
Danes et al., 2012). More generic model systems often employ
neurotoxins such as 6-hydroxydopamine or 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) to induce degeneration of the
A9 dopaminergic neurons. In thesemodels of PD the neurotoxin-
induced degeneration of the A9 neurons appears to be dependent
upon the activity of tumor necrosis factor alpha (TNF) which is
elevated in the striatal tissue of mice and rats following the injec-
tion of MPTP or 6-hydroxydopamine (Mogi et al., 1999; Sriram
et al., 2002). Critically, suppression of TNF reduces neurodegen-
eration in these model systems (McCoy et al., 2006, 2008; Sriram
et al., 2006). While the underlying causes of PD are the subject of
much speculation, this evidence of a role for TNF in the degen-
erative process is consistent with oxidative stress contributing
to PD. In this system a transient initiating factor (an infection
or neurotoxin) triggers a chronic cycle of neuroinﬂammation
which promotes clustering of activatedmicroglia in the basal gan-
glia and striatum of patients with PD, promoting degeneration
(Gerhard et al., 2006). Microglia are important regulators of neu-
ron function. In addition to phagocytic activity, they are capable
of releasing trophic factors, such as brain cell line-derived neu-
rotrophic factor (BDNF; Nagatsu and Sawada, 2007), as well as a
number of pro-inﬂammatory mediators, including chemokines,
reactive oxygen and nitrogen species, prostaglandin E2 and TNF.
Both TNF and TNF receptor (R1) are elevated in the cere-
brospinal ﬂuid and nigral tissue of patients with PD (Mogi et al.,
1994, 2000). Also, patients with gain of function mutations in the
TNF promoter region show an increased risk of early onset PD
(Nishimura et al., 2001; Bialecka et al., 2008). In spite of this evi-
dence there is no direct empirical evidence linking TNF with the
death of human A9 neurons.
One of the major problems underlying mechanistic investi-
gations of the role of TNF in human neurodegeneration has
been the lack of an adequate in vitro system to facilitate these
investigations. Human stem cell cultures and methods to push
neurons toward a dopaminergic neuron fate have improved con-
siderably over the last 6–7 years. However, a major problem
with hPSC-derived mDA neural cultures is that current dif-
ferentiation protocols, even the few that can be replicated in
other laboratories (such as Kriks et al., 2011), still generate a
heterogeneous mix of cells in culture that make it diﬃcult to
observe or quantify eﬀects. To address this shortcoming we have
created a human homologous recombinant stem cell line that
expresses a ﬂuorescent reporter gene (eGFP) under the con-
trol of a midbrain speciﬁc DA neural endogenous promoter
(PITX3) to enable the identiﬁcation of PITX3-eGFP positive
(PITX3eGFP/w) mDA neurons within the culture. We now report
that PITX3eGFP/w neurons are evident from day 20 of diﬀer-
entiation although they take approximately 70 days to reach
functional maturity; deﬁned by low levels of intracellular chlo-
ride and resting calcium. These neurons are responsive to a
number of pharmacological stimuli, but the pharmacological
responsiveness of these neurons changes as they mature: early
in the course of maturation individual neurons are likely to
respond to any of the neurotransmitters, ATP, glutamate, nora-
drenaline, and acetylcholine with elevations of intracellular cal-
cium, but as these neurons mature they are likely to become
responsive to all four ligands. At maturity the PITX3eGFP/w
neurons show a transcript proﬁle indicative of mDA neurons
(including PITX3, tyrosine hydroxylase, and TUJ1). We assessed
the ability of a neurotoxin (MPP+) as well as neuroinﬂamma-
tory mediators TNF and prostaglandin E2 to promote neuron
death and neurite retraction of these cultures. MPP+ is a pow-
erful toxin in these cells and TNF, but not PGE2, causes some
death as well as neurite retraction. In summary, we show that
PITX3eGFP/w neurons are ideal tools for the investigation of
mDA neuron development, the pharmacological characterization
of receptor populations, as well as in vitro neurodegeneration
studies.
Materials and Methods
hPSC Culture and PITX3eGFP/w Cell Line
Generation Using Zinc-Finger Nucleases
The initial hPSC line (H9) was cultured on MEFs (mitomycin C
treatedmouse embryonic ﬁbroblasts, 4× 105 cells cm−2) in hPSC
media: Dulbecco’s Modiﬁed Eagle Medium: Nutrient Mixture
F-12 (DMEM/F12, 1:1; Invitrogen, Australia), 20% Knock-Out
Serum (Invitrogen, Australia), 1% NEAA, 2 mM GlutaMAXTM-
I, penicillin 25 U mL−1, streptomycin 25 μg mL−1, 0.1 mM
β-mercaptoethanol and 6 ng mL−1 FGF-2. Media was changed
daily. hPSC cultures were manually groomed to remove diﬀeren-
tiated colonies. Fragments (∼0.5 mm2 diameter) were manually
passaged every 5–7 days onto freshly prepared MEFs.
To create the PITX3 homologous recombinant cell line,
pluripotent H9 human embryonic stem cells (hESCs) were
harvested using Accutase and plated on 0.1% v/v gelatin
coated dishes in hPSC media containing Rho-associated protein
kinase inhibitor (10 μM, Y-27632; Cellagen Technology, USA).
Following 30 min incubation the non-adherent hPSCs were col-
lected, centrifuged (200× g, 5 min), resuspended (7.5× 106 cells)
in 800 μL of 0.22 μm ﬁltered ice cold PBS and transferred to
a 0.4 cm electroporation cuvette (Bio-Rad, Australia) together
with 10 μg of custom designed ZFN pairs (Sigma-Aldrich,
Australia) and 40 μg of a previously described EGFP targeting
vector (Hockemeyer et al., 2009) obtained from Addgene (USA).
Electroporation was conducted at 250 V, 500 μF (GenePulser
XCell instrument; Bio-Rad, Australia) and the electroporated
cells plated on MEFs in hPSC medium containing a ROCK
inhibitor for the ﬁrst 24 h. Individual colonies were incubated
with puromycin (0.5 μg mL−1, Invitrogen, Australia) for 10–
14 days after electroporation, at which time puromycin resistant
colonies were manually picked and expanded for screening.
For screening correctly targeted colonies, genomic DNA was
prepared as previously described (Nefzger et al., 2012). Pooled
colonies were initially screened by PCR using the Expand
Long Template PCR System (Roche, Australia). PCR positive
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clones were then further screened by Southern blotting. Digested
genomic DNA was electrophoresed, transferred to Hybond-
N+ membranes (GE Healthcare, Australia) and hybridized with
external probes complementary to sequences upstream of the
5′ homology arm of the vector and downstream of the 3′
homology arm, as well as an internal puromycin probe. Probes
were labeled with α-32P-dATP (Perkin Elmer, Australia) using
a DECAprimeTM II kit (Ambion, Texas) and hybridized in
ULTRAhybTM hybridization buﬀer (Ambion, Texas). The signal
was detected using Kodak BioMax MS ﬁlm in a BioMax Cassette
with BioMax TranScreen HE (Sigma-Aldrich, Australia).
PITX3eGFP/w Neuron Differentiation and
Visualization
For diﬀerentiation, PITX3eGFP/w hPSC fragments were trans-
ferred to Geltrex (Stem Cell Technologies, Australia) coated
six well-plates in mTeSR-1 (Stem Cell Technologies, Australia)
media. After 3 days, or when wells were 50–60% conﬂuent,
cells were washed thrice in 1X PBS and grown thereafter in a
1:1 mixture of modiﬁed Neurobasal and modiﬁed DMEM/F12
medium (N2B27 media; Brewer et al., 1993). Additives to
this medium were based on the conditions found in Kriks
et al. (2011) and included LDN 193189 (LDN, 100 nM; Axon
Medchem, Netherlands) from days 0 to 10, SB 431542 (SB,
10 μM; Sigma-Aldrich, Australia) from days 0 to 5, recombi-
nant mouse Sonic Hedgehog C25II (SHH, 100 ng mL−1; R&D
Systems, USA), recombinant mouse ﬁbroblast growth factor-
8b carrier-free (FGF8, 100 ng mL−1; R&D Systems, USA), and
purmorphamine (PUR, 2 μM; Santa Cruz Biotechnology, USA)
from days 1 to 7, CHIR 99021 (CHIR, 3 μM; Tocris Bioscience,
USA) from days 3 to 13, and recombinant human glial cell line-
derived neurotrophic factor (GDNF (20 ng mL−1; R&D Systems,
USA), recombinant human BDNF (20 ng mL−1; R&D Systems,
USA), ascorbic acid (AA, 200 nM; Sigma-Aldrich, USA), DAPT
(10 nM; Sigma-Aldrich, USA), N6, 2′-O-dibutyryladenosine-3′ ,
5′-cyclic monophosphate (db-cAMP, 0.5 mM; Biolog Life Science
Institute, Germany), and recombinant human TGF-β 3 (TGF-β,
1 ng mL−1; R&D Systems, USA) from day 10 onward. Cells could
be grown on the Geltrex plates until at least day 80 of diﬀerentia-
tion (with every-other-day media changes); alternatively after day
20 fragments of cells (roughly 2–3 mm in diameter) could be gen-
tly cut away from growing colonies using the tip of a P200 pipette
and transferred to laminin (1 mg mL−1) coated plates. Colonies
were grown in supplemented N2B27 (as described above) until
experimentation. eGFP ﬂuorescence during diﬀerentiation was
conﬁrmed using ﬂow cytometry (below), and visualized with a
Nikon A1R confocal microscope (Nikon Instruments, USA).
Flow Cytometry and Sorting
To characterize diﬀerentiating cultures, starting at day 0 of dif-
ferentiation and continuing at 3 days intervals until day 21,
cells were dissociated using Accutase (Sigma-Aldrich, Australia),
and resuspended in 1X HBSS (Invitrogen, Australia) containing
10% FCS, and 2 mM glucose at 37◦C for cytometric analysis of
eGFP ﬂuorescence. Cell suspensions were strained (40 μm; BD
Biosciences, Australia) to minimize clumps, and incubated with
5 nM SYTOX Blue (Invitrogen, Australia) to stain for dead cells.
Analysis was performed on a FACS Canto II ﬂow cytometer (BD
Biosciences, Australia). eGFP ﬂuorescence exclusion gating was
employed to ensure that >99% of the wild type control popu-
lation (also subjected to the same staining) were eGFP-negative.
The key to neuron survival using this approach is to have as low
a pressure, and as wide a nozzle as possible.
Cells were also FACS sorted for mRNA extraction and subse-
quent qPCR. On days 0, 20, 40, 60, and 80, cells were dissociated
using accutase, strained, and resuspended as above. FACS was
performed using a MoFlo Astrios sorter (Beckman Coulter Inc.,
USA) and cells divided into eGFP positive and eGFP negative
fractions. The positive and negative fractions from the aggregates
of three independently diﬀerentiating wells (to ensure suﬃcient
cells for each sort) were centrifuged at 200 × g for 5 min and the
supernatant removed prior to RNA extraction.
RNA Extraction and Quantitative-PCR
Total RNAwas extracted from 106 cells using the RNEasyMinikit
according to manufacturer’s instructions (Qiagen, Australia).
Samples were analyzed for RNA content using the Nanodrop
ND-1000 (Thermo Scientiﬁc, USA) spectrophotometer. Three
technical replicate qPCR reactions were performed on sam-
ples aggregated from three independently diﬀerentiating wells
using the iScript One-Step RT-PCRKit with SYBR-Green accord-
ing to the manufacturer’s speciﬁcations (Bio-Rad, Australia).
qPCR reactions and primer sequences are described in Table 1.
Relative quantiﬁcation of gene expression during diﬀerentiation
was obtained using the 2−Ct method (Livak and Schmittgen,
2001) by comparing Ct values of target genes to mean Ct values
of two housekeeping genes, β-actin and GAPDH.
Immunocytochemistry
Immunocytochemistry was carried out as previously described
(Khaira et al., 2009). Brieﬂy, cells were washed free of PBS/sodium
azide (3 × 5 min in PBS) and permeabilized with 0.1% Triton
X-100 (Sigma-Aldrich, Australia) in PBS for 30 min at room tem-
perature. Cells were then blocked with 1% normal donkey serum
in PBS for 30 min and incubated overnight in 0.1% Triton X-
100 in PBSwith the primary antibodies, anti-tyrosine hydroxylase
(TH; rabbit IgG, 1:200; Millipore, Australia), anti-βIII tubulin
(mouse IgG, 1:1000; Covance, Australia), anti-FOXA2 (mouse
IgG, 1:1000; DHSB, USA), anti-GABA (rabbit IgG, 1:200; Sigma-
Aldrich, Australia), anti-GIRK2 (rabbit IgG, 1:200; Alomone
labs, Israel), and anti-LMX1A (rabbit IgG, 1:200; Sigma-Aldrich,
Australia). Cells were then incubated with the secondary antibod-
ies donkey anti-mouse Alexa Fluor 488 and donkey anti-rabbit
Alexa Fluor 594 (both Molecular Probes, USA) at 1:1000 for 2 h at
room temperature. Cells were visualized using a Nikon TE2000U
microscope coupled to a SPOT RT camera (for post live-cell
imaging immunocytochemistry) or a Nikon A1R confocal micro-
scope (for other immunocytochemistry; Nikon, Japan). Fields of
view corresponding with those used for Ca2+ and Cl− ion imag-
ing studies were identiﬁed by aligning initial images with those
taken after immunolabeling. TH immunoreactive and eGFP pos-
itive (TH+eGFP+) neurons were identiﬁed and regions deﬁned
so that [Ca2+]i and [Cl−]i responses in those neurons could be
determined after replaying the initial live cell experiments.
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TABLE 1 | Quantitative polymerase chain reactions (qPCRs) were
performed in the C1000 Thermal Cycler coupled to a CFX96 Real Time
System (Bio-Rad, Australia).
Gene Fwd/Rev Sequence 5′ to 3′ Melt ◦C
TH Fwd CGG GCT TCT CGG ACC AGG TGT A 73.2
Rev CTC CTC GGC GGT GTA CTC CAC A 72.6
AADC Fwd CTC GGA CCA AAG TGA TCC AT 63.9
Rev GTC TCT CTC CAG GGC TTC CT 63.8
NURR1 Fwd TTC TCC TTT AAG CAA TCG CCC 66.1
Rev AAG CCT TTG CAG CCC TCA CAG 69.8
PITX3 Fwd GCC AAC CTT AGT CCG TG 59.2
Rev GCA AGC CAG TCA AAA TG 57.8
DAT Fwd AGC AGA ACG GAG TGC AGC T 65.4
Rev GTA TGC TCT GAT GCC GTC T 60.5
FOXG1 Fwd TGG CCC ATG TCG CCC TTC CT 75.1
Rev GCC GAC GTG GTG CCG TTG TA 73.5
NKX2.1 Fwd AGG GCG GGG CAC AGA TTG GA 75.1
Rev GCT GGC AGA GTG TGC CCA GA 71.4
PAX5 Fwd CCC CAT TGT GAC AGG CCG TGA C 74.8
Rev TCA GCG TCG GTG CTG AGT AGC T 70.5
EN1 Fwd TCT CGC TGT CTC TCC CTC TC 63.9
Rev CGT GGC TTA CTC CCC ATT TA 63.6
WNT1 Fwd GAG CCA CGA GTT TGG ATG TT 64.0
Rev TGC AGG GAG AAA GGA GAG AA 64.0
GIRK2 Fwd GCT ACC GGG TCA TCA CAG AT 63.9
Rev ACT GCA TGG GTG GAA AAG AC 63.9
LMX1A Fwd CGC ATC GTT TCT TCT CCT CT 63.4
Rev CAG ACA GAC TTG GGG CTC AC 65.0
FOXA2 Fwd GGG GTA GTG CAT CAC CTG TT 63.8
Rev CCG TTC TCC ATC AAC AAC CT 63.9
SHH Fwd CCA ATT ACA ACC CCG ACA TC 63.9
Rev AGT TTC ACT CCT GGC CAC TG 64.3
CORIN Fwd CAT ATC TCC ATC GCC TCA GTT G 65.6
Rev GGC AGG AGT CCA TGA CTG T 62.9
HOXA2 Fwd CGT CGC TCG CTG AGT GCC TG 74.1
Rev TGT CGA GTG TGA AAG CGT CGA GG 72.7
ACTB Fwd CCT TGC ACA TGC CGG AG 66.9
Rev GCA CAG AGC CTC GCC TT 64.6
GAPDH Fwd TTG AGG TCA ATG AAG GGG TC 63.9
Rev GAA GGT GAA GGT CGG AGT CA 64.6
OCT4 Fwd TCT CCA GGT TGC CTC TCA CT 64.1
Rev GTG GAG GAA GCT GAC AAC AA 62.9
MAP2 Fwd CCG TGT GGA CCA TGG GGC TG 75.3
Rev GTC GTC GGG GTG ATG CCA CG 75.4
SYP Fwd ACC TCG GGA CTC AAC ACC TCG G 72.6
Rev GAA CCA CAG GTT GCC GAC CCA G 73.8
Reaction conditions included cDNA synthesis (10 min at 50◦C), reverse transcrip-
tase inactivation (5 min at 95◦C), PCR cycling (10 s at 95◦C then 30 s at 55–60◦C;
up to 43 cycles), and melt curve analysis (1 min at 95◦C, 1 min at 55◦C, and 10 s
each at steps of 0.5◦C between and 55–95◦C). Primers used in gene expression
assay.
Live Cell Calcium and Chloride Ion Imaging
Calcium and chloride ion imaging was performed on days 20, 40,
60, and 80 as described previously (Haynes et al., 2002; Watmuﬀ
et al., 2012). For calcium imaging; neurons were incubated in
HEPES buﬀered salt solution (consisting of NaCl, 145 mM; KCl,
5 mM; MgSO4, 1 mM; HEPES, 10 mM; CaCl2, 2 mM; glucose,
10 mM, containing 0.1% bovine serum albumin, at pH 7.4) in the
presence of 5 μM FURA-2AM (ICN Biochemicals) for 40 min.
Cells were then allowed to hydrolyze the acetoxymethyl ester for
40–60 min (37◦) prior to viewing with a Nikon TE2000U micro-
scope coupled to a SPOT RT camera (for post live-cell imaging
immunocytochemistry) or a Nikon A1R confocal microscope.
Cell temperature was maintained at near 37◦C with a heated
stage. A DG4 (Sutter, USA) was used to illuminate cells with
light at 340 and 380 nm. Cell ﬂuorescent emission at 510 nm was
recorded every 1–2 s. Background emission was subtracted from
each image, and 340/380 ratios of the resultant intensity emission
values at each time point were obtained.
For intracellular calcium quantitation, the calcium concentra-
tion was calculated using the equation (Grynkiewicz et al., 1985):
[Ca2+]i=KDβ [(R − Rmin) / (Rmax − R)]
Where β is the emission ratio of Rmin/Rmax at 380 nm.
The dissociation constant (KD) value of 285 nM was taken
from (Groden et al., 1991). The Rmin value was obtained
in the absence of Ca2+ and in the presence of both 4-Br-
A232187 (20 μM) and EGTA (10 mM). The Rmax value was
obtained in the presence of both 4-Br-A232187 (20 μM) and
Ca2+ (10 mM).
For non-quantitative calcium imaging neurons were loaded
with Fluo4AM (10 μM 30 min) as described previously (Khaira
et al., 2011). Brieﬂy, following a 30 min equilibration period
minute equilibration period and 10 min of baseline imaging
either of the agonists adenosine triphosphate (ATP, 300 μM),
noradrenaline (NA, 30 μM), acetylcholine (ACh, 30 μM), L-
glutamate (Glut, 30 μM), γ-aminobutyric acid (GABA, 30 μM;
all Sigma-Aldrich, Australia), We have previously shown these
concentrations to be eﬀective in elevating [Ca2+]i in mDA
neurons (Lang et al., 2004; Raye et al., 2007; Khaira et al.,
2011) Following peak response or after 5 min, wells were
washed three times with PBS and preparations allowed at
least 5 min to recover before the addition of the next ago-
nist. This was repeated until all ﬁve agonists had been added.
After the ﬁnal agonist addition wells were washed and KCl
(30 mM) added.
For voltage operated calcium channel inhibitor studies cells
were loaded with Fluo-4AM (as described above). Following a
10 min equilibration period KCl (30 mM) was added to cul-
ture plates and changes in ﬂuorescence intensity recorded over
30 s. Preparations were then washed and nifedipine (10 μM) was
added, 5 min later KCl was added again and changes in ﬂuores-
cence intensity recorded. Preparations were washed and nifedip-
ine re-added, along with ω-conotoxin (0.4 μM) and responses to
KCl measured again. This process was repeated with the addition
of mibefradil (10 μM). Control responses to KCl (30 mM, x4)
were measured in the presence voltage operated calcium channel
inhibitor vehicle.
For chloride ion imaging we used the method previ-
ously described (Watmuﬀ et al., 2012). Brieﬂy, we incubated
neurons with the Chloride-sensitive ﬂuorophore dihydro-MEQ
(10 μM; Ingleﬁeld and Schwartz-Bloom, 1999) in normal HEPES
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buﬀer, measuring ﬂuorescence intensity following excitation at
340/26 nm; emission was recorded at 510/84 nm. Resting state
ﬂuorescence and ﬂuorescence following the addition of GABA
(30 μM) were recorded. We changed to a Cl− free buﬀer (normal
HEPES with gluconate ions replacing Cl−) containing nigericin
(10 μM), tributyltin (10 μM), and valinomycin (5 μM) to mea-
sure minimum ﬂuorescence. 10 min later Cl− was added back
into the tissue buﬀer at 0.1, 1, 10, and 100 mM, allowing a
Stern–Volmer relationship to be constructed (where F0/F denotes
ﬂuorescence in the absence of chloride divided by ﬂuorescence
in the presence of chloride), this relationship was used to con-
struct a chloride ion standard curve from which neuron [Cl−]i
was calculated (Krapf et al., 1988).
Following each experiment cells were ﬁxed 4% (w/v)
paraformaldehyde in PBS for 25 min at room temperature and
then stored in PBS with 0.1% sodium azide (Sigma-Aldrich,
Australia) until used for immunocytochemistry.
Dopamine ELISA
On days 20, 40, 60, and 80 of diﬀerentiation neurons were
incubated with HEPES buﬀer (37◦C) containing nipecotic acid
(6 μM) and AA (200 μM). The HEPES buﬀer was collected
from each well 60 s after the application of KCl (30 mM), GABA
(30 μM), Glut (30 μM), or vehicle. The order of addition of
agents was randomized in each experiment. Following collec-
tion, samples were immediately frozen by placing vials on dry
ice and then stored in liquid nitrogen until use. ELISA was
performed using the dopamine ELISA kit (Genway Biotech.,
USA) according to the manufacturer’s instructions. Optical den-
sity at 405 nm was measured immediately after the reaction was
stopped using an EnVision 2.101 multilabel ﬂuorescence plate
reader (PerkinElmer, Australia) and dopamine concentrations of
samples were interpolated using the standard curve generated.
Neurodegeneration Assay
Cells were diﬀerentiated for 80–90 days. eGFP was visualized
using a Nikon A1R confocal microscope equipped with an envi-
ronmental chamber to allow neuron survival. Z-plane stacks
of PITX3eGFP/w neurons were taken every 2 h for up to 48 h.
Ligands were added immediately following the ﬁrst round of
imaging (time = 0 h). Cell loss was deﬁned by the fraction
of eGFP ﬂuorescence remaining in each ﬁeld of view follow-
ing the addition of MPP+ (50 μM), TNF (20 ng mL−1), PGE2
(300 nM), or vehicles. In some experiments the cell imperme-
ant nuclear acid stain TO-PROR©-3 (1 nM; Invitrogen, Australia)
was added to wells to establish when neuron membranes became
permeable. PITX3eGFP/w neuron-containing ﬁelds of view were
analyzed using Nikon Elements imaging software (Nikon, Japan).
For analysis of neuron death, stacks of images were used to
create maximum intensity projection images, which were then
thresholded for eGFP. Given the presence of ﬂuorescent beads
developing in cultures images, especially after the addition of
TNF, small ﬂuorescent objects (with areas of less than <50 μm2)
were excluded from analysis prior. The total ﬂuorescence area
was then calculated before and after ligand and used to generate a
ratio (post-ligand/pre-ligand). We also measured neurite length
over time using the maximum intensity projection images, single
cells with clear eGFP+ projections were identiﬁed from pre-
ligand images and the neurites manually measured with a tracing
tool. For this study we found the 2 h imaging to be invaluable
since it enabled us to trace neurite outgrowth/retraction, even as
the soma moved around the plate.
Statistical Analysis
Results are presented as the arithmetic mean ± standard
error of the mean (SEM) of at least three independent exper-
iments. Statistical analyses were performed using GraphPad
Prism v5.00 and later v6.00 (GraphPad Software, USA) and
employed a Student’s t-test (two-tailed), or one-way analysis
of variance (ANOVA) with post hoc Bonferroni’s or Dunnett’s
test as appropriate. Paired t-tests were used when treatments
allowed for ‘before and after’ measurements of cell responses
in live cell experiments. For experiments involving single cell
measures of ﬂuorescence intensity, n = 3, 60 cells indicates
that changes were measured in 60 cells spread across three
(temporally distinct) independent diﬀerentiations (∼20 cells per
diﬀerentiation).
Results
Generation of hPSC Reporter Line and
Differentiation of PITX3eGFP/w Neurons
A ZFN pair together with a targeting vector was used to intro-
duce an eGFP-puromycin cassette to pluripotent H9 hESCs at
exon 1 of the endogenous PITX3 locus (Figure 1A). Targeting
eﬃciency was 19% of total colonies picked and was conﬁrmed
with southern blot analysis (Figure 1B). A modiﬁed version of
a recently described ﬂoor plate diﬀerentiation protocol (Kriks
et al., 2011; summarized in Figure 2A) was used to derive mDA
neurons. Neural diﬀerentiation was evident by the polarization
of cell bodies and increased size of initial colonies by day 4
(Figure 2B). By day 12 of diﬀerentiation wells were largely con-
ﬂuent, by day 20, small (10–20 μm) polar neuronal cell bodies
could be seen (Figure 2B). From day 8 eGFP ﬂuorescence positive
cells were visible (Figure 2C). Wild type H9 cells diﬀerentiated
under the same conditions did not show any eGFP ﬂuorescence,
nor did PITX3eGFP/w hPSCs diﬀerentiated without fate directing
morphogens (i.e., SHH, FGF8, or CHIR; data not shown). Flow
cytometry was used to quantify the emergence of eGFP during
diﬀerentiation (Figure 2D). The number of eGFP+ cells present
per well-increased from 0 at day 0 to 14.9 ± 0.3% by day 12, this
remained stable until day 21 (Figure 2E; one-way ANOVA with
post hoc Dunnett’s test compared to day 0, p < 0.05 and 0.001,
n = 3).
Differentiated PITX3eGFP/w Cells Display
Transcript, Protein, and Functional
Capabilities of Midbrain Dopaminergic
Neurons
Maturation of cultures by re-plating onto laminin coated wells
revealed bright eGFP+ cell bodies clearly evident from days 20
to 80 of diﬀerentiation (Figure 2F). These cells displayed neu-
ronal morphology and possessed eGFP throughout their soma
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FIGURE 1 | Targeting eGFP to the endogenous PITX3 locus in hPSCs
using zinc finger nucleases (ZFN). (A) shows a schematic of the donor
plasmid for targeting eGFP to the endogenous PITX3 locus; the strategy
employed was based on that reported by Hockemeyer et al. (2009). PGK,
human phosphoglycerol kinase promoter; PURO, puromycin resistance gene;
loxP, loxP sites; pA, polyadenylation sequence. (B) Correctly targeted colonies
(as determined by PCR) were generated with 19% efficiency, and subsequently
confirmed by Southern blot analysis (modified from Hartley et al., 2014).
and associated processes (Figure 2F). Comparative gene expres-
sion analysis via quantitative PCR (qPCR) was performed on
eGFP positive and negative fractions (plot shown in Figure 3A)
collected via FACS at day 20, 40, 60, and 80 of diﬀerentiation.
Between 4 and 8% live eGFP+ cells were collected on each sort
(Figure 3A). eGFP+ sorted cells revealed an up-regulation of
markers of the dopaminergic neuron phenotype; DAT, AADC,
and TH as well as the ﬂoor plate markers FOXA2, SHH, CORIN,
and the midbrain markers LMX1A, WNT1, EN1, PITX3, and
PAX6 at all time points compared to hPSCs (Figure 3B; one-
way ANOVA with post hoc Dunnett’s test, p < 0.05, n = 3).
eGFP+ cells also showed high levels of the neuronal marker
MAP2, and the synaptic marker SYP (Figure 3B; one-way
ANOVA, p < 0.05, n = 3). The forebrain markers NKX2.1 and
FOXG1, as well as the hindbrain marker HOXA2, were pre-
dominantly expressed in the eGFP− fraction (Figure 3C). SYP
and MAP2 enrichment were also found in the eGFP− fraction
(Figure 3C).
Next, we conﬁrmed transcriptional proﬁling of eGFP+ cells
using immunocytochemistry. Confocal microscopy at day 20
revealed abundant expression of the neuronal cytoskeletal pro-
tein β-III tubulin (TUJ1) as well as TH (Figure 4A). 96 ± 2%
of TH+ cells were TUJ1+ (Figures 4B,C). eGFP+ cells also co-
expressed TH (94 ± 2% of eGFP+ cells), FOXA2 (97 ± 1%
of eGFP+ cells), LMX1A (90 ± 3% of eGFP+ cells), and the
K+ inward-rectifying channel, GIRK2 (56 ± 4% of eGFP+ cells;
(Figures 4B,C). GABA immunoreactivity was widespread from
day 20 onward, but was rarely co-localized with eGFP (1 ± 1%;
Figures 4B,C).
Functional Properties of PITX3eGFP/w
Neurons Develop During In Vitro
Differentiation
To determine whether PITX3eGFP/w neurons were functional
we performed live-cell ﬂuorescent imaging to measure intra-
cellular calcium ([Ca2+]i) and chloride ion ([Cl−]i) activity, as
well as DA release during diﬀerentiation (Figure 5A). From
day 20 around 20% of PITX3eGFP/w neurons (which were sub-
sequently shown to be immunoreactive to TH) showed regular
spontaneous elevations of [Ca2+]i (Figure 5B) at a frequency of
3.3 ± 0.3 min−1 (Figure 5C). By day 80 the frequency of these
events was 5.0 ± 0.1 min−1 (Figure 5C; change from days 20 to
80 was not signiﬁcant, one-way ANOVA with post hoc Dunnett’s
test, p> 0.05, n= 3). [Ca2+]i in PITX3eGFP/w neurons was calcu-
lated at rest and after stimulation with KCl (30 mM; Figure 5D).
Basal [Ca2+]i increased during diﬀerentiation from 45 ± 13 nM
at day 20 to 169± 25 nM at day 80 (Figure 5E; one-way ANOVA,
p < 0.001, n = 4, 60–80 cells). KCl (30 mM) increased maximal
[Ca2+]i from 357 ± 80 nM at day 20 to 931 ± 119 nM at day 80
(Figure 5E; one-way ANOVA, p < 0.001, n = 4, 60–80 cells).
[Cl−]i was calculated in PITX3eGFP/w neurons at rest and
after stimulation with GABA (30 μM; Figure 5F). Basal [Cl−]i
decreased during diﬀerentiation from 5.8 ± 0.4 mM at day 20 to
2.1 ± 0.4 mM at day 80 (Figure 5F; one-way ANOVA, p < 0.001,
n = 4, 60–80 cells). At day 20, GABA signiﬁcantly decreased
basal [Cl−]i, but by day 80 GABA elevated basal [Cl−]i (Student’s
paired t-test, p < 0.001, n = 4, 60–80 cells). The proportion of
PITX3eGFP/w neurons responding to GABA with an elevation of
[Cl−]i increased from 12% at day 20 to 82% at day 80 (Figure 5G).
Cultures containing PITX3eGFP/w neurons released DA both
at rest, and following pharmacological stimulation using GABA
(30 μM), Glut (30 μM), and KCl (30 mM; Figure 5F). Basal
release of DA in culture increased during diﬀerentiation from
2.1 ± 0.3 ng mL−1 at day 20 to 3.22 ± 0.05 ng mL−1
at day 80 (Figure 5F; one-way ANOVA with post hoc
Dunnett’s test, p < 0.01, n = 3). DA release following
stimulation with GABA (30 μM) was 3.93 ± 0.86 ng mL−1
at day 20. By day 40, post-GABA DA release decreased
and remained constant until day 80 (0.05 ± 0.16 ng mL−1;
Figure 5H; one-way ANOVA with post hoc Dunnett’s test,
p < 0.001, n = 3).
Next, the ability of PITX3eGFP/w neurons to respond to
common neurotransmitters was investigated using Fluo-4 Ca2+
imaging. At days 20, 40, 60, and 80 PITX3eGFP/w cells responded
to ATP (300 μM), GABA (30 μM), KCl (30 mM), NA (30 μM),
Glut (30 μM), ACh (30 μM), and Ca2+ (10 mM) with elevations
of [Ca2+]i (percentages of eGFP+ cells responding to each
neurotransmitter are shown in Figure 6A). Figure 6B shows
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FIGURE 2 | PITX3eGFP/wcells appear during chemically defined
monolayer differentiation. (A) PITX3eGFP/w hPSCs were transferred in
fragments to Geltrex coated plates in mTeSR media. After 3 days, or
when wells became 50–60% confluent, differentiation was initiated in
N2B27 media using containing LDN 193189 (LDN), SB 431542 (SB),
recombinant mouse/human Sonic Hedgehog C25II (SHH), recombinant
mouse fibroblast growth factor-8b (FGF8), purmorphamine (PUR), CHIR
99021 (CHIR), recombinant human glial cell line-derived neurotrophic factor
(GDNF), recombinant human brain cell line-derived neurotrophic factor
(BDNF), ascorbic acid (AA), DAPT, N6, 2′-O-dibutyryladenosine-3′ , 5′-cyclic
monophosphate (db-cAMP), and recombinant human TGF-β 3 (TGF-β). (B)
Cell morphology transitioned from PSC fragments to immature neurons by
day 20. (C) Cell bodies containing eGFP could be seen developing
across cultures from day 8 to day 22 of differentiation. (D) The
percentages of live eGFP+ cells in culture were observed using flow
cytometry. (E) shows the percentage of live eGFP+ cells to day 21
(one-way ANOVA with post hoc Dunnett’s test compared to day 0, ∗
indicates p < 0.05 and ∗∗∗ indicates p < 0.001, n = 3). (F) Upon
extended differentiation, eGFP+ cells with neuronal morphology were seen
in culture until at least day 80. Scale bars; 100 μm.
the typical responses of cells responding to ATP from each time
point, and also the mean (±SEM) increase in Ca2+-related ﬂu-
orescence after ATP at each time point. PITX3eGFP/w neuron
responsiveness to individual agents was close to 100% by day 80;
the exception being NA, which elicited elevations of [Ca2+]i in
<50% of cells (Figure 6A). We next looked at the ability of indi-
vidual PITX3eGFP/w neurons to respond to multiple agonists in
order to ascertain whether they became functionally restricted
to speciﬁc pharmacological stimuli during maturation. At day 20
only 10± 9% of cells responded to all the neurotransmitters (ATP,
ACh, NA, and Glut) with elevations of intracellular calcium. By
day 80, this ﬁgure had risen to 48 ± 21% of all PITX3eGFP/w neu-
rons (Figure 6C; one-way ANOVA with post hoc Dunnett’s test,
p > 0.05, n = 3, 40–60 cells).
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FIGURE 3 | Transcriptional identity of PITX3eGFP/w cells is midbrain
dopaminergic. A second flow cytometry experiment was conducted to collect
eGFP+ and eGFP− cells for total RNA extraction and qPCR analysis on days
20, 40, 60, and 80. (A) Shows a typical FACS plot at day 20, and the strategy
used to isolate eGFP+ and eGFP− cells. This graph shows the percentage of
live cells (from three independent experiments; ± SEM) sorted into the eGFP+
gate at each time point. (B) qPCR analysis of the mRNA from at least 106
eGFP+ cells showed upregulation of neuronal and midbrain dopaminergic
genes (compared to hPSCs; one-way ANOVA with post hoc Dunnett’s test,
p < 0.001-0.05, n = 3 technical replicates of samples aggregated from three
independently differentiating wells) at points between days 20 and 80 of
differentiation. The y-axis shows the fold change in mRNA levels ( mRNA). (C)
Shows a heat map of the ratio of mean transcript levels in the positive fraction :
negative fraction. Fore, forebrain; mid, midbrain; floor, floorplate; hind, hindbrain.
Lastly, in order to investigate the contribution of voltage oper-
ated Ca2+ channels to the KCl-induced elevations of [Ca2+]i we
examined the KCl-induced elevation of [Ca2+]i in the absence
and presence of three speciﬁc voltage operated Ca2+ chan-
nel inhibitors, added cumulatively, nifedipine (10 μM; L-type
blocker), ω-conotoxin MVIIA [0.4 μM; N (primarily)/P/Q type
blocker] and mibefradil (10 μM, T type blocker; Figure 6C).
Nifedipine reduced the KCl-induced elevation of [Ca2+]i by 27%
(one-way ANOVA with post hoc Dunnett’s test, p < 0.05, n = 3,
60–80 cells). The subsequent addition of ω-conotoxin to nifedip-
ine had no further eﬀect on KCl-induced elevations of [Ca2+]i,
but the addition of mibefradil to the combination ofω-conotoxin
and nifedipine further reduced the KCl-induced elevation of
[Ca2+]i by 59% (Figure 6C; one-way ANOVA with post hoc
Dunnett’s test, p < 0.001, n = 3, 60–80 cells).
PITX3eGFP/w Neuron Responses to MPP+
and Neuroinflammatory Mediators
To establish PITX3eGFP/w neurons as a tool for modeling neu-
rodegeneration in PD we tested the eﬀects of the neurotoxin
MPP+, as well as two neuroinﬂammatory mediators: TNF, as
well as prostaglandin E2 [PGE2, which is elevated in response
to MPP+ (Wang et al., 2005)] on mature PITX3eGFP/w neu-
rons. Figures 7A,B show a typical ﬁeld of view before (7A) and
24 h after TNF (20 ng mL−1, 7B). After 24-h exposure, MPP+
(5 μM) signiﬁcantly (one-way ANOVA with post hoc Dunnett’s
test, p < 0.05, n = 4 wells) reduced eGFP+ cell number by
49± 13%. TNF (20, but not 2 ng mL−1), PGE2 was without eﬀect
(Figure 7C, n = 10). Around 50% of cells were resistant to TNF,
even when the incubation was continued for 72 h (not shown).
When neurons did not clearly die we were able to measure GFP+
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FIGURE 4 | PITX3eGFP/w cells express protein markers of midbrain
dopaminergic neurons. Immunocytochemical analysis of PITX3eGFP/w
cultures was performed at day 20 in order to confirm the presence of
an mDA neuronal phenotype. (A) Wells were replete with the neuronal
marker β-III tubulin (TUJ1; green), which was almost always co-localized
with the dopaminergic marker tyrosine hydroxylase (TH; red). The panels,
from left to right, show low and high powered color-merges of TUJ1
and TH, in combination with the nuclear stain TO-PRO-3 (blue). (B)
Immunocytochemical analysis of PITX3eGFP/w cultures was performed at day
20 in order to confirm the presence of an mDA neuronal phenotype.
Populations of PITX3eGFP/w cells expressed mDA markers TH, FOXA2,
LMX1A, and the A9 group marker GIRK2, but not the GABAergic marker
GABA. (C) Shows the relative co-localization of protein markers at day 20.
The columns represent the percentage of cells positive for both markers
(data presented as mean ± SEM, n = 3 fields of view from independent
wells). Scale bars; 100 μm.
neurite lengths using Nikon software. Compared to vehicle con-
trol, TNF, but not PGE2 signiﬁcantly (one-way ANOVAwith post
hoc Dunnett’s test, p < 0.05, n = 10 and 12) reduced neurite
length over this time (Figure 7D). A lower concentration of TNF
(2 ng mL−1 for 24 h) had no eﬀect on neurite length (not shown).
Discussion
Current mDA diﬀerentiation protocols yield heterogeneous neu-
ral cultures with mixed neurotransmitter and regional speciﬁca-
tions. The ﬁrst aim of this study was to generate a homologous
hPSC reporter line to facilitate the identiﬁcation, isolation, and
characterization of mature mDA neurons. The second aim was
to assess the responses of these neurons to pharmacological and
toxicological stimuli. The endogenous PITX3 promoter was cho-
sen to drive eGFP since, in the adult CNS, PITX3 expression
is restricted to DA neurons of the midbrain (Smidt et al., 1997,
2012), it also has a demonstrable role in the development, matu-
ration, and survival of mDA neurons (Nunes et al., 2003). PITX3-
driven eGFP could be seen as early as day 8 of diﬀerentiation,
from day 20 to termination, cultures contained 10–15% intensely
ﬂuorescent and clearly identiﬁable PITX3eGFP/w neurons.
To investigate the transcriptional changes in the PITX3eGFP/w
neurons we used ﬂow cytometry to collect eGFP+ cells at days
20, 40, 60, and 80. Although ﬂow cytometry became more diﬃ-
cult over time as cultures developed extensive neuronal processes,
we were consistently able to collect around 8% live cells for
total RNA extraction. The transcriptional proﬁle of PITX3eGFP/w
cells was indicative of an mDA phenotype, with both the mid-
brain and ﬂoor plate markers; PITX3, EN1, PAX5, FOXA2, SHH,
and CORIN highly upregulated compared to eGFP− cells. In
addition, the eGFP+ population showed a down-regulation of
the anterior and posterior CNS markers, NKX2.1, FOXG1, and
HOXA2. In contrast, LMX1A and WNT1 were, unexpectedly,
relatively down-regulated at various time points in the eGFP+
fraction compared to the eGFP− fraction. Although LMX1A and
WNT1 encode critical mediators of early dopaminergic speci-
ﬁcation (Chung et al., 2009), they are also involved in other
neural diﬀerentiation programs; for example, LMX1A also directs
early forebrain fate while WNT1 is involved in neural crest dif-
ferentiation (Sarnat and Flores-Sarnat, 2005). Thus we think
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FIGURE 5 | Functional characterization of PITX3eGFP/w neurons reveals
development of maturity during terminal differentiation. (A) Ca2+ and
Cl− imaging was employed to probe the function of PITX3eGFP/w neurons.
These panels show, from left to right, eGFP in a field of view prior to
imaging, the Ca2+ -sensitive probe Fluo-4 loaded into cells of the same
field, and TH and eGFP after post-imaging immunocytochemistry. (B) Shows
a representative trace from a Ca2+ imaging experiment. Spontaneous
oscillations of [Ca2+]i , typical of in vitro mDA neurons are highlighted by
arrows. The y-axis represents change in fluorescence: baseline fluorescence
(F/F). (C) The frequency of these oscillations did not change significantly by
day 80 (one-way ANOVA with post hoc Dunnett’s test, indicates p > 0.05,
n = 3 wells, 60–80 cells). (D) Intracellular calcium ion concentration ([Ca2+ ]i )
in PITX3eGFP/w neurons was calculated at rest and after stimulation with KCl
(30 mM). (E) Basal and KCl-induced elevations of [Ca2+]i increased during
differentiation (one-way ANOVA with post hoc Dunnett’s test, ∗∗∗ indicates
p < 0.001, n = 3 experiments, 40–80 cells). (F) Similarly, GABA (30 mM)
decreased [Cl−]i at day 20 and 40 of differentiation, by day 80 GABA
induced a significant increase in [Cl]i (Student’s paired t-test, ∗∗∗ indicates
p < 0.001, n = 4, 60–80 cells). (G) By day 80 most PITX3eGFP/w neurons
respond to GABA with an elevation of [Cl− ]i (blue; R2 = 0.99), rather than
the decrease seen at earlier days of differentiation (red; R2 = 0.99). (H)
Shows the change in dopamine concentration in the supernatant of eGFP+
cultures following vehicle addition (i.e., basal level), GABA (30 mM),
L-glutamate (30 mM) or KCl (30 mM) at different days of culture. Dopamine
release in response to GABA (30 μM), but not L-glutamate or KCl
significantly decreased from days 20 to 80 of differentiation (one-way ANOVA
with post hoc Dunnett’s test compared to day 20, ∗∗, ∗∗∗ indicates
p < 0.01 and 0.001, respectively, n = 3 wells).
it is likely that LMX1A and WNT1 may be expressed in the
eGFP− population as part of these other programs. As the cul-
tures developed it became clear that the midbrain and ﬂoor plate
markers FOXA2, SHH, CORIN, and PAX5 expression decreased
in eGFP+ cells, most likely as a consequence of neuronal mat-
uration (Matsushita et al., 2002). This idea was supported by our
data showing the presence ofDAT transcript after day 60, possibly
indicating the development of synaptic interactions. Consistent
with this idea, the synaptic marker SYP was highly upregulated
in the eGFP+ fraction, indicating the likely formation of func-
tional synapses (Wiedenmann and Franke, 1985). Our proﬁling
data are therefore consistent with the idea that PITX3 express-
ing neurons continue to develop during maturation and terminal
diﬀerentiation.
We then used immunocytochemistry to conﬁrm the tran-
scriptional proﬁle of developing PITX3eGFP/w neurons. Thus,
TH, FOXA2 and LMX1A immunoreactivity was present in
most PITX3eGFP/w neurons. GIRK2 was not present in all
PITX3eGFP/w neurons, however, possibly indicating subpopula-
tions of mDA neurons (Thompson et al., 2005), or perhaps dis-
tinct stages in development. GABAergic immunoreactivity was
observed during diﬀerentiation, however, it was rarely found in
PITX3eGFP/w cells.
Functionally, the PITX3eGFP/w neurons displayed sponta-
neous elevations of [Ca2+]i and were capable of sponta-
neous, GABA sensitive dopamine release. The variation in
concentration of dopamine released during diﬀerentiation may
be attributable to the state of maturity of the developing cultures:
immature mDA neurons release dopamine to aid development
through D2 autoreceptor-mediated Nurr1 activation (Kim et al.,
2006), whereas mature neurons release dopamine predominantly
through classic neurotransmitter release signaling (Snyder, 2011).
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FIGURE 6 | Neuropharmacology of PITX3eGFP/w neurons. Ca2+ imaging
of eGFP+ cells revealed functional neurons responding to neurotransmitters
changes over time. (A) Shows the percentages of eGFP+ cells, at days 20
and 80 of differentiation, that respond to pharmacological stimuli with
increases of [Ca2+ ]i >10 SD of baseline (mean ± SEM, n = 3). ATP,
adenosine triphosphate; NA, noradrenaline; Glut, L-glutamate; ACh,
acetylcholine; or V, vehicle. For example, at day 20 very few eGFP+ cells
respond to all of ATP, NA, Ach and glutamate, this figure increases to ∼50%
of neurons at day 80. (B) Shows typical PITX3eGFP/w neuron [Ca2+ ]i
responses to ATP on days 20–80. Mean fold changes in [Ca2+ ]i-related
fluorescence in response to ATP (±SEM) are shown underneath. (C) Shows
the effect of the cumulative addition of calcium channel inhibitors, nifedipine
(10 μM), ω-conotoxin MVIIA (0.4 μM), and mibefradil (10 μM) on the
KCl-induced change in [Ca2+ ]i at day 80. KCl (30 mM) control responses in
the presence of voltage operated calcium channel inhibitor vehicles did not
significantly change throughout the experiment. All data was analyzed using
a one way ANOVA with post hoc Dunnett’s test compared to vehicle or day
20 data. (∗ and ∗∗∗ indicates p < 0.05 and 0.001, n = 3).
These properties of PITX3eGFP/w neurons are largely consistent
with our current understanding of mDA neuron function in vivo
(Overton and Clark, 1997; Ji et al., 2009). To conﬁrm neuronmat-
uration in culture we tested PITX3eGFP/w neurons with live cell
ion imaging studies as previously described (Lang et al., 2004;
Raye et al., 2007; Khaira et al., 2011). As cultures matured we
also saw both a decrease in [Cl−]i as well as an increase in the
proportion of PITX3eGFP/w neurons responding to GABA with
increased [Cl−]i. These ﬁndings are consistent with a shift from
immature to mature cultures (Rivera et al., 1999; Payne et al.,
2003). As [Cl−]i decreased, basal [Ca2+]i increased across cul-
tures, lending support to the idea that following the expression of
PITX3, neurons continue a relatively slow process of functional
maturation.
These PITX3eGFP/w neurons responded to ATP, NA, ACh,
and Glut with elevations of [Ca2+]i, indicating they were func-
tionally responsive to multiple neurotransmitters. As cultures
developed it became evident that more neurons responded to
a greater number of ligands. Mouse PSC-derived TH+ neurons
demonstrate variability in their responses to diﬀerent neuro-
transmitters, at a time when cultures are mature (Raye et al.,
2007; Watmuﬀ et al., 2012), however, the present results indi-
cate that extended diﬀerentiation of hPSC-derivedmDA neurons
results in a more homogenous pharmacological response to these
neurotransmitters. Although we have not further characterized
the receptors present, our functional data are broadly consis-
tent with reports of the presence of ionotropic and metabotropic
glutamate, GABA, acetylcholine and ATP receptor transcripts in
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FIGURE 7 | PITX3eGFP/w neuron death following MPP+ and TNF. (A)
Typical representative images of PITX3eGFP/w green neurons prior to (A) and
after the addition of TNF (20 ng mL−1, 24 h, B). (C) Effects of MPP+ (5 μM) and
tumor necrosis factor (20 ng mL−1), both 24 h on neurons survival (as defined
by maintenance of somal fluorescence) (one way ANOVA with post hoc
Dunnett’s test compared to vehicle, ∗ indicates p < 0.05, n = 3–12
differentiations). Prostaglandin E2 (300 nM) was without significant effect (not
shown; D). Surviving neurons show neurite retraction following incubation with
TNF (20 ng/ml), but not prostaglandin E2 (300 nM). Data presented as
mean ± SEM (one way ANOVA with post hoc Dunnett’s test compared to
vehicle, ∗ indicates p < 0.05, n = 6–12 differentiations). For death assays
n = 6–12 fields of view. For fluorescent neurite tracing neurites length is
expressed as a fraction of original length (i.e., pre-ligand) n = 4, with
measurements taken from 16 neurons. Scale bar; 100 μm.
human substantia nigra (see for example, E-GEOD-7621 and E-
GEOD-20333; http://www.ebi.ac.uk/). These tissues samples also
reveal multiple α- and β- adrenergic receptors, a ﬁnding consis-
tent with our evidence that noradrenaline is capable of elevating
intracellular calcium in PITX3eGFP/w neurons.
VOCCs are present on mDA neurons in vivo (Catterall, 2011)
and their tightly controlled activation contributes to the spon-
taneous activity observed in rodent dopaminergic neurons (see
Marinelli et al., 2006). Our observation of spontaneous oscil-
lations of intracellular calcium is likely to result from bursts
of spontaneous electrical activity, clearly these events require
extensive electrophysiological characterization before conclu-
sions about their signiﬁcance can be drawn. We also showed
that a high concentration of nifedipine and as well as mibefradil,
but not MVIIA reduced the elevation in [Ca2+]i following KCl
depolarization, indicating a role for L- and T- type VOCCs in
hPSC-derived neuronal Ca2+ signaling. While we acknowledge
that the single concentrations of inhibitor used in this study are
not optimal we argue that the eﬀects we see most likely indicate
that these channels are present and functional in these cultures.
Clearly, there is a need for further electrophysiological studies to
pursue the identity and function of these channels. In addition,
our studies are somewhat spatially limited in that they account
only for Ca2+ channel present in the soma and they in no way
allow prediction of which channel subunits may be present on
the soma vs. dendrites; it is for example, dendritic calcium that
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regulates spontaneous activity, at least in dissociated rat neurons
(Kim et al., 2013). It is evident from array data (see E-GEOD-7621
and E-GEOD-20333; http://www.ebi.ac.uk/) that multiple voltage
gated channel subunits may be present in the human substantia
nigra, but how these channels cooperate to regulate spontaneous
bursts of activity is unclear.
Intracellular chloride decreases as neurons mature, a phe-
nomenon that corresponds to a GABA related depolarization of
immature neurons (Ben-Ari et al., 2007). Our cultured neurons
showed a signiﬁcant decrease in intracellular chloride over dif-
ferentiation which correlates with a change in response to GABA
where, early in diﬀerentiation GABA was a depolarizing agent,
capable of reducing intracellular chloride, later in diﬀerentia-
tion it increased intracellular chloride and inhibited dopamine
release. Together these ﬁnding indicate a developing neuronal
culture that largely consists of mature neurons from day 60 of
diﬀerentiation. This last point is an important consideration as
it demonstrates the importance of choosing an appropriate time
for experimentation or implantation, although the fundamen-
tal signiﬁcance of this work remains that PITX3eGFP/w neurons
are most useful for neuropharmacological or neurophysiological
studies (albeit from at least 60 days in culture).
In our next series of experiments we investigated the eﬀects
of the neurotoxin MPP+ and two neuroinﬂammatory media-
tors, TNF and PGE2 on PITX3eGFP/w neuron survival and neu-
rite retraction. We chose these ligands since TNF is elevated
in the striatal tissue of mice and rats following the injection
of the neurotoxins, MPTP or 6-hydroxydopamine (Mogi et al.,
1999; Sriram et al., 2002), while mice lacking TNF receptors
are insensitive to the eﬀects of MPTP (Sriram et al., 2002).
Furthermore the TNF inhibitor protein, dominant negative
TNF, protects substantia nigral dopaminergic neurons against 6-
hydroxydopamine-induced neuronal toxicity (McCoy et al., 2006;
Harms et al., 2011). Thus evidence linking TNF to the initiation
and progression of PD is strong. In contrast to TNF, PGE2 has
four cognate receptor subtypes, EPR1-4. Carrasco et al. (2007)
have found that EPR2 activation protects mDA neurons against
low levels of oxidative stress while EPR1 activation renders mDA
neurons vulnerable to such stress. A 24 h exposure to TNF, but
not PGE2 signiﬁcantly reduced the number of eGFP ﬂuorescent
cell bodies in culture and also induced the retraction of GFP+
neurites. Death of neurons occurred within 16 h of TNF addition,
but neurite retraction was maximal at 24 h. Signiﬁcantly, our
data indicates that not all PITX3eGFP/w neurons were sensitive
to the eﬀects of TNF possibly indicating the presence of sub-
types of PITX3eGFP/w neurons. Whether this diﬀerence equates
to the diﬀerence between nigral and ventral tegmental dopamin-
ergic neurons, or reﬂects the largely unknown identities of other
cells in each well, is currently unknown.
As a ﬁnal step we assessed PITX3eGFP/w neuron survival fol-
lowing the addition of the neurotoxin, MPP+. MPTP, the precur-
sor of MPP+ is a well-described dopaminergic neurotoxin that
is likely to produce excessive levels of reactive oxygen species
and or an inhibition of mitochondrial activity to kill neurons
(Smeyne and Jackson-Lewis, 2005). In this study a 24 h expo-
sure to MPP+ signiﬁcantly reduced eGFP ﬂuorescence, a ﬁnding
consistent with its reported activities in vivo and in vitro. Of
signiﬁcance is a report by Luk et al. (2013) who suggest that
the absence of one allele of Pitx3 in a mouse system increases
sensitivity of TH+ neurons to MPTP. This work may indicate
some potential for PITX3 haploinsuﬃciency to increase the sen-
sitivity of these PITX3+ neurons to neurotoxin-mediated death.
However, we would argue that, in the absence of neurotoxic
insult, these neurons are readily maintained in culture for at least
80 days. We interpret this as evidence that suﬃcient PITX3 is
present to maintain survival.
Conclusion
We believe that progress in determining factor(s) that initi-
ate and sustain idiopathic PD is hampered by the lack of a
suitable in vitro model of human mDA neuron function. The
hPSC PITX3eGFP/w reporter cell line described here has the
potential to accelerate advancement in neurobiology, neurophar-
macology, neurophysiology, and neurotoxicology as it permits
the identiﬁcation, sorting and tracking of live and dying mDA
neurons in culture. These PITX3eGFP/w neurons show both recep-
tor expression and activities that appear consistent with animal
models and, more importantly, human array data. In particu-
lar we believe that these PITX3eGFP/w neurons will become a
powerful tool in drug discovery biology as they readily permit
investigation of the mechanisms underlying neuron function and
degeneration.
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